Coagulation Test Names
that Are Confusing
·
The most common purpose for ordering the factor V activity assay is to
help with the differential diagnosis of liver disease.
·
The factor V assay is also ordered to establish the presence of an
inherited factor V deficiency. These are very rare and are associated with
severe bleeding in infancy.
The factor V Leiden mutation is present in 3-8% of Caucasians and
Hispanics and confers a 2- to 8-fold risk of thrombosis (80-fold when
homozygous). The factor V Leiden mutation test is usually ordered as part of a
profile that includes antithrombin (AT, ATIII), protein C (PC), protein S (PS),
factor VIII (for elevated factor VIII), prothrombin 20210 mutation, and lupus
anticoagulant (LAC).
When the factor V Leiden mutation assay is ordered, the laboratory first
performs the activated protein C resistance (APCR) assay, which is an effective screen. The factor
V Leiden mutation molecular test is only performed when the APCR ratio is less
than 1.8.
The factor X assay is used mostly to diagnose congenital factor X
deficiency, a very rare disorder that causes severe bleeding beginning in infancy.
The anti-Xa test (anti-factor Xa, or anti-activated factor X) is used to
monitor heparin therapy. It may be ordered to monitor standard, unfractionated
heparin when the partial thromboplastin time (PTT) cannot be used, such as when
the patient has the lupus anticoagulant. The anti-Xa test is the only test that works for monitoring low molecular weight heparin such as LovenoxÒ or FragminÒ, or synthetic heparin such as DanaparoidÒ.